Pharmaceuticals And Life Sciences

To secure confidential high-value information, companies often aggregate these in a small number of repositories. However it is important to ensure that these systems are highly resilient against sophisticated and targeted cyber-attacks.

Having confidence that information ‘crown jewels’ are proportionally protected is vital. Yet this must not prevent the benefits from new technology and working structures. Ensuring that information is available when required to the appropriate individuals while also ensuring that the confidentiality and integrity of the information is assured can enable companies to deliver innovative products to market in a timely fashion.

As part of PA Consulting Group, we are also able to combine our technical cyber security services with deep industry knowledge and skills in management consulting, technology and innovation.

Related Insight

  • Trojan

    CYBER BITESIZE - Threat #2: Trojans

    In the second article in the series, CYBER BITESIZE, PA & 7Safe's Michael Shuff defines Trojans.
    Read more

Related Case Studies

  • 15

    Safeguarding information assets for a global pharmaceutical business

    For our client, a global pharmaceutical company, the sudden resignation of their IT security officer ...
  • 1895

    Defending design IP and physical assets in the pharmaceutical sector

    Our client, a global pharmaceutical organisation, was migrating to an outsourced infrastructure and asked us ...